Select Medical Holdings had a strong Q4 and 2019 with all business segments exceeding previous year's revenue, adjusted EBITDA, and margin. Net revenue for Q4 increased 8.7% to $1.37 billion and 7.3% to $5.45 billion for the year. Adjusted EBITDA also rose, by 16.9% to $171.9 million in Q4 and 10.2% to $710.9 million for the year. It also reported increases in adjusted earnings per fully diluted share of $0.11 to $0.31 for Q4 and $0.14 to $1.24 for the year. For 2020, Select Medical Holdings forecasts net revenue of $5.575 billion to $5.675 billion, adjusted EBITDA of $725 million to $760 million and fully diluted earnings per share of $1.27 to $1.46.